| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
KLF6 SV1 Blocking Peptide for STJ501556 is synthetically produced from the 170-220 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: |
170-220 |
| Specificity: |
This blocking peptide is recommended for use in combination with KLF6 SV1 antibody, STJ501556 |
| Immunogen: |
Synthetic peptide taken within amino acid region 170-220 on human KLF6 protein. |
| Background | Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
